Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dare Bioscience Inc (DARE)

Dare Bioscience Inc (DARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dare Bioscience Announces Publication of a Peer-Reviewed Journal Article Supporting the Use of the Postcoital Test Study as a Predictor of Contraceptive Effectiveness by Biology of Reproduction

Includes positive clinical findings from a postcoital test (PCT) human clinical study of Ovaprene(R), an investigational hormone-free, monthly contraceptive

DARE : 0.9903 (-0.97%)
Dare Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis

Dare Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the initiation of the DARE-BVFREE study, a multi-center, double-blind, placebo-controlled Phase 3 clinical study...

DARE : 0.9903 (-0.97%)
Dare Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive

Dare Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the receipt by its wholly owned subsidiary of $1.5 million in additional grant funding from the Bill & Melinda...

DARE : 0.9903 (-0.97%)
Dare Bioscience Announces Participation in BIO Digital 2020

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that the company will participate in the BIO International Convention, which will be held in a new, virtual...

DARE : 0.9903 (-0.97%)
Dare Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update

Conference Call Today at 4:30 p.m. Eastern Time

DARE : 0.9903 (-0.97%)
Dare Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Dare's Novel Pipeline of Women's Health Programs

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, and Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women's health clinical research...

DARE : 0.9903 (-0.97%)
Dare Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 14, 2020, to...

DARE : 0.9903 (-0.97%)
Dare Bioscience CEO to Participate in Maxim Group's Infectious Disease Virtual Conference

Dare Bioscience, Inc.(NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion...

DARE : 0.9903 (-0.97%)
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today...

STIM : 1.8300 (-2.66%)
DARE : 0.9903 (-0.97%)
ANIK : 38.37 (-0.52%)
Dare Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced it entered into a $15 million common stock purchase agreement and registration rights agreement with Lincoln...

LPBC : 7.2000 (unch)
DARE : 0.9903 (-0.97%)
Dare Bioscience Receives Third Notice of Award from National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the Development of Ovaprene(R)

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced it received a Notice of Award of $730,722 in a grant supporting the Ovaprene(R) postcoital test (PCT) clinical...

DARE : 0.9903 (-0.97%)
Dare Bioscience Reports 2019 Financial Results and Provides a Company Update

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today reported financial results for the year ended December 31, 2019 and provided a company update.

DARE : 0.9903 (-0.97%)
Dare Bioscience to Host Fourth Quarter and Full-year 2019 Financial Results and Company Update Conference Call and Webcast on March 30, 2020

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on March 30, 2020, to review...

DARE : 0.9903 (-0.97%)
Dare Bioscience Receives FDA Fast Track Designation for DARE-BV1 for the Treatment of Bacterial Vaginosis

DARE-BV1 demonstrated an 86% clinical cure rate in evaluable subjects at the test-of-cure visit after a single administration in an investigator-initiated proof of concept study, which is higher than the...

DARE : 0.9903 (-0.97%)
Dare Bioscience Presents Positive Sildenafil Cream, 3.6% Data Supporting Further Development for the Treatment of Female Sexual Arousal Disorder

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced the presentation of positive findings from a previously reported investigational study that used thermography...

DARE : 0.9903 (-0.97%)
Dare Bioscience to Present at the Cowen 40th Annual Health Care Conference

Dare Bioscience, Inc.(NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will present at the Cowen 40 Annual Health...

DARE : 0.9903 (-0.97%)
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company's Board of Directors since August 2018, has been named interim Chief Executive Officer, effective...

STIM : 1.8300 (-2.66%)
DARE : 0.9903 (-0.97%)
ANIK : 38.37 (-0.52%)
Dare Bioscience Regains Compliance with Nasdaq Minimum Equity Rule and Secures Capital to Advance Product Candidates

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, announced that it has been notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum...

DARE : 0.9903 (-0.97%)
Dare Bioscience to Present at the 2020 BIO CEO & Investor Conference

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor...

DARE : 0.9903 (-0.97%)
Dare Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, announced that it was notified by the Nasdaq Office of General Counsel that the Company regained compliance with the minimum...

DARE : 0.9903 (-0.97%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.44 , SEDG +1.72 , THC -0.26 , TER +1.67 , LITE +2.08
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar